Skip to main content
Equibles

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP

Position in SUPN — Supernus Pharmaceuticals, Inc.

CIK 1164508 BOSTON, MA
Back to SUPN Full portfolio

Position in SUPN

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$3,320,488
+$2,927,903 QoQ
Shares Held
71,393
+840.0% QoQ
Ownership
0.123%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#80
of 335 holders
Holding Since
Mar 2020
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SUPN Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP holds $921,160,135 across 28 Drug Manufacturers - Specialty & Generic names. SUPN ranks #19 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 3,137,442 $225,456,582
2 VTRS
Viatris Inc
 8,371,218 $132,934,941
3 HLN
Haleon plc
 14,181,817 $132,316,352
4 INDV
Indivior Pharmaceuticals, Inc.
 1,642,086 $67,374,788
5 KNSA
Kiniksa Pharmaceuticals International, plc
 957,514 $61,233,020
6 TAK
Takeda Pharmaceutical Co Ltd
 3,732,924 $59,838,771
7 ANIP
Ani Pharmaceuticals Inc
 562,016 $46,523,684
8 ELAN
Elanco Animal Health Inc
 1,872,157 $46,073,783

All Filings in SUPN

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,320,488 71,393
2026-03-31 $392,585 7,595
2025-12-31 $9,129,293 183,688
2025-09-30 $10,820,133 226,410
2025-06-30 $7,816,235 247,977
2025-03-31 $8,397,296 256,406
2024-12-31 $6,324,962 174,916
2024-09-30 $3,040,767 97,523
2022-12-31 $1,394,875 39,105
2022-09-30 $306,139 9,044
2020-09-30 $3,743,510 179,631
2020-06-30 $3,736,302 157,318
2020-03-31 $509,117 28,300